Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Biolyst
AddedFeb 18, 2024
UpdatedJun 18, 2026
Biolyst

Biolyst

Seed

Realief™ Neuropathy Centers offers patented, data-backed treatments for peripheral neuropathy, aiming to bring real relief nationwide.

HQ
Brooklyn Park, MN, US
Founded
2010
Overview
Compare
Fundraising
Employees
Website

Biolyst, operating as Realief™ Neuropathy Centers, is dedicated to providing innovative pain management solutions for peripheral neuropathy. Their mission is to alleviate symptoms such as pain, numbness, tingling, burning, and balance issues through a proprietary treatment protocol backed by clinical data. With locations across the United States, including North Carolina, South Carolina, Wisconsin, Minnesota, Arizona, and Nevada, Realief™ aims to deliver effective, individualized care nationwide.

Realief™ Neuropathy Centers have achieved significant milestones by publishing validated data from an extensive patient registry and conducting peer-reviewed, randomized, placebo-controlled, double-blind clinical trials. Their commitment to evidence-based treatments sets them apart in the field of neuropathy care. The centers' continuous improvement of treatment protocols ensures they remain at the forefront of neuropathy therapy, providing real relief to countless patients.

Biolyst - Similar Companies

Global Pain Center logo

Global Pain Center

Neuright logo

Neuright

neurightlabs.com

NeuroTherapeutics Pharma logo

NeuroTherapeutics Pharma

WinSanTor logo

WinSanTor

winsantor.com

NeuraLace Medical logo

NeuraLace Medical

Neuropathix logo

Neuropathix

neuropathix.com

Relevium Medical logo

Relevium Medical

Neuropure logo

Neuropure

Pacira BioSciences logo

Pacira BioSciences

pacira.com

Alleviate logo

Alleviate

Medx Back Pain Clinics. logo

Medx Back Pain Clinics.

medx.clinic

Neuraptive Therapeutics logo

Neuraptive Therapeutics

neuraptive.com

4e Therapeutics logo

4e Therapeutics

Neuraly logo

Neuraly

neuralymed.com

American Pain Consortium logo

American Pain Consortium

Biolyst - Quick Facts

Who are Biolyst's competitors?

Companies similar to Biolyst include Global Pain Center, Neuright, NeuroTherapeutics Pharma and WinSanTor.

When was Biolyst founded?

Biolyst was founded in 2010.

Where is Biolyst's headquarters located?

Biolyst's headquarters is located in Brooklyn Park, MN, US.

When was Biolyst's last funding round?

Biolyst's most recent funding round was for $458k (USD) in August 2013.

How much has Biolyst raised to-date?

As of Aug 1, 2013, Biolyst has raised a total of $458k (USD).

How many employees does Biolyst have?

Biolyst has 6 employees as of Feb 5, 2024.

Biolyst - Classification

Industry
  • Professional Service Companies
Ownership
  • Private
Technology
  • HealthTech
Geographic Exposure
  • United States
Revenue
  • Recurring
Customer
  • Consumers
Main Product
  • Pain Management
Tags
  • Healthcare
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
SIC
  • 5000Wholesale Trade-durable Goods
  • 5040Professional And Commercial Equipment And Supplies
  • 5047Medical, Dental, And Hospital Equipment And Supplies
Show 7 more industry codes
NAICS
  • 330000Manufacturing
  • 620000Health Care and Social Assistance
  • 623000Nursing and Residential Care Facilities
SIC
  • 3900Miscellaneous Manufacturing Industries
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified